| Product Code: ETC11530686 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Companion Diagnostic Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Companion Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Austria Companion Diagnostic Market - Industry Life Cycle |
3.4 Austria Companion Diagnostic Market - Porter's Five Forces |
3.5 Austria Companion Diagnostic Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 Austria Companion Diagnostic Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Austria Companion Diagnostic Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.8 Austria Companion Diagnostic Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.9 Austria Companion Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Austria Companion Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Austria leading to higher demand for companion diagnostics |
4.2.2 Growing adoption of personalized medicine in healthcare practices |
4.2.3 Technological advancements in molecular diagnostics and genomics research |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for companion diagnostic development and approval |
4.3.2 High cost associated with companion diagnostic tests and treatments |
4.3.3 Limited reimbursement policies for companion diagnostics in Austria |
5 Austria Companion Diagnostic Market Trends |
6 Austria Companion Diagnostic Market, By Types |
6.1 Austria Companion Diagnostic Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Austria Companion Diagnostic Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 Austria Companion Diagnostic Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.1.4 Austria Companion Diagnostic Market Revenues & Volume, By Immunohistochemistry, 2021 - 2031F |
6.1.5 Austria Companion Diagnostic Market Revenues & Volume, By Next-Gen Sequencing, 2021 - 2031F |
6.1.6 Austria Companion Diagnostic Market Revenues & Volume, By Mass Spectrometry, 2021 - 2031F |
6.2 Austria Companion Diagnostic Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Austria Companion Diagnostic Market Revenues & Volume, By Drug Response Testing, 2021 - 2031F |
6.2.3 Austria Companion Diagnostic Market Revenues & Volume, By Biomarker Testing, 2021 - 2031F |
6.2.4 Austria Companion Diagnostic Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.2.5 Austria Companion Diagnostic Market Revenues & Volume, By Disease Identification, 2021 - 2031F |
6.3 Austria Companion Diagnostic Market, By Disease Area |
6.3.1 Overview and Analysis |
6.3.2 Austria Companion Diagnostic Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.3 Austria Companion Diagnostic Market Revenues & Volume, By Cardiology, 2021 - 2031F |
6.3.4 Austria Companion Diagnostic Market Revenues & Volume, By Neurology, 2021 - 2031F |
6.3.5 Austria Companion Diagnostic Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.4 Austria Companion Diagnostic Market, By Sample Type |
6.4.1 Overview and Analysis |
6.4.2 Austria Companion Diagnostic Market Revenues & Volume, By Blood, 2021 - 2031F |
6.4.3 Austria Companion Diagnostic Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.4.4 Austria Companion Diagnostic Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.4.5 Austria Companion Diagnostic Market Revenues & Volume, By Urine, 2021 - 2031F |
6.5 Austria Companion Diagnostic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Austria Companion Diagnostic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 Austria Companion Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5.4 Austria Companion Diagnostic Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5.5 Austria Companion Diagnostic Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
7 Austria Companion Diagnostic Market Import-Export Trade Statistics |
7.1 Austria Companion Diagnostic Market Export to Major Countries |
7.2 Austria Companion Diagnostic Market Imports from Major Countries |
8 Austria Companion Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of personalized medicine in Austria |
8.2 Investment in research and development of companion diagnostics |
8.3 Number of collaborations and partnerships between diagnostic companies and pharmaceutical firms |
8.4 Percentage of healthcare providers offering companion diagnostic testing services |
8.5 Patient outcomes and treatment efficacy with the use of companion diagnostics |
9 Austria Companion Diagnostic Market - Opportunity Assessment |
9.1 Austria Companion Diagnostic Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 Austria Companion Diagnostic Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Austria Companion Diagnostic Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
9.4 Austria Companion Diagnostic Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
9.5 Austria Companion Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Austria Companion Diagnostic Market - Competitive Landscape |
10.1 Austria Companion Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Austria Companion Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here